- Home
- GBIO vs ZEPP Comparison
GBIO vs ZEPP Comparison
Compare GBIO & ZEPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBIO
- ZEPP
- Stock Information
- Founded
- GBIO 2016
- ZEPP 2013
- Country
- GBIO United States
- ZEPP Netherlands
- Employees
- GBIO N/A
- ZEPP N/A
- Industry
- GBIO Biotechnology: Pharmaceutical Preparations
- ZEPP Computer Manufacturing
- Sector
- GBIO Health Care
- ZEPP Technology
- Exchange
- GBIO Nasdaq
- ZEPP Nasdaq
- Market Cap
- GBIO 29.2M
- ZEPP 34.1M
- IPO Year
- GBIO 2020
- ZEPP N/A
- Fundamental
- Price
- GBIO $0.38
- ZEPP $2.43
- Analyst Decision
- GBIO Strong Buy
- ZEPP
- Analyst Count
- GBIO 4
- ZEPP 0
- Target Price
- GBIO $7.33
- ZEPP N/A
- AVG Volume (30 Days)
- GBIO 558.2K
- ZEPP 19.8K
- Earning Date
- GBIO 08-06-2025
- ZEPP 05-19-2025
- Dividend Yield
- GBIO N/A
- ZEPP N/A
- EPS Growth
- GBIO N/A
- ZEPP N/A
- EPS
- GBIO N/A
- ZEPP N/A
- Revenue
- GBIO $24,556,000.00
- ZEPP $181,183,000.00
- Revenue This Year
- GBIO N/A
- ZEPP $758.69
- Revenue Next Year
- GBIO N/A
- ZEPP N/A
- P/E Ratio
- GBIO N/A
- ZEPP N/A
- Revenue Growth
- GBIO 146.47
- ZEPP N/A
- 52 Week Low
- GBIO $0.32
- ZEPP $2.06
- 52 Week High
- GBIO $3.65
- ZEPP $4.38
- Technical
- Relative Strength Index (RSI)
- GBIO 48.07
- ZEPP 47.59
- Support Level
- GBIO $0.35
- ZEPP $2.25
- Resistance Level
- GBIO $0.41
- ZEPP $2.44
- Average True Range (ATR)
- GBIO 0.03
- ZEPP 0.14
- MACD
- GBIO -0.00
- ZEPP 0.00
- Stochastic Oscillator
- GBIO 30.11
- ZEPP 49.90
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.
About ZEPP Zepp Health Corporation
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.